Join the Dermatitis group to help and get support from people like you.
Dermatitis News
American Academy of Dermatology, March 8 to 12
The annual meeting of the American Academy of Dermatology was held from March 8 to 12 in San Diego and attracted participants from around the world, including clinicians, academicians, allied health...
Atopic Dermatitis in Children Tied to Learning, Memory Difficulties
TUESDAY, March 12, 2024 – Pediatric atopic dermatitis (AD) is associated with greater odds of reported difficulties in learning and memory, but this association is driven by children with ...
Sun Plus Certain Foods, Meds Can Bring on 'Margarita Rashes'
MONDAY, March 11, 2024 – Slicing some fresh limes for that margarita savored in the sun could be a bad combo for some people's skin, dermatologists warn. Folks can break out in what are nicknamed...
AAD: Concerns Noted Relating to Use of AI Dermatology Apps
FRIDAY, March 8, 2024 – There are notable concerns relating to the use of currently available artificial intelligence (AI) dermatology mobile applications (apps), according to a study published...
Skin of Color Underrepresented in AI Programs in Dermatology
WEDNESDAY, March 6, 2024 – Challenges relating to artificial intelligence (AI) in dermatology and its application to skin of color (SOC) are partly due to underrepresentation of SOC in datasets,...
Updated Guidelines Released for Management of Atopic Dermatitis
THURSDAY, Dec. 28, 2023 – In updated guidelines issued by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology, and published online Dec. 17 in...
Children With Eczema More Likely to Have Allergic Contact Dermatitis
MONDAY, Oct. 2, 2023 – Children with atopic dermatitis (AD) are more likely to have positive patch test (PPT) reactions, according to a study published online Sept. 25 in the Journal of the American...
Crisaborole Effective for Long-Term Maintenance in Mild-to-Moderate Eczema
WEDNESDAY, June 28, 2023 – Crisaborole is effective as a long-term maintenance therapy for pediatric and adult patients with mild-to-moderate atopic dermatitis (AD), according to a study published...
Mindfulness, Self-Compassion Training Improves QOL in Eczema
WEDNESDAY, May 10, 2023 – A mindfulness and self-compassion training intervention is effective for improving quality of life (QOL) among adults with atopic dermatitis, according to a study published...
New Hope Against Painful Skin Issues Caused by Cancer Radiation Therapy
MONDAY, May 8, 2023 – When Ann Alexander underwent chemotherapy to treat breast cancer a decade ago, she was warned about potential hair loss, nausea and vomiting. The 73-year-old wasn’t, however, t...
FDA Approves Adbry (tralokinumab-ldrm) for Adults with Moderate-to-Severe Atopic Dermatitis
MADISON, N.J.--(BUSINESS WIRE) December 28, 2021 --LEO Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Adbry™ (tralokinumab-ldrm) for the treatment of m...
FDA Approves Dupixent (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis
TARRYTOWN, N.Y. and PARIS, May 26, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupi...
FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Atopic Dermatitis in Adolescents
CAMBRIDGE, Mass. and TARRYTOWN, N.Y., March 11, 2019 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for adolescent patients 12 to 17 years of age with...
FDA Approves Dupixent (dupilumab) for Eczema
March 28, 2017 – The U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for...
FDA Approves Eucrisa (crisaborole) for Eczema
December 14, 2016 – The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older....
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Eczema, Contact Dermatitis, Atopic Dermatitis, Poison Ivy, Dermatological Disorders
Related drug support groups
clobetasol, triamcinolone, fluocinonide, prednisolone, desonide, halobetasol